Anavasi Diagnostics | Nelson Patterson, CEO
Anavasi Diagnostics is a molecular diagnostic company using miniaturized RT-LAMP technology to provide lab-quality molecular diagnostic results in the CLIA-waived / POC environment, and eventually, the home -- in 30 minutes, on average.
CytoVeris | Alan Kersey, President & CEO
CytoVeris is harnessing precise, smart cancer imaging solutions, by converging advanced optical imaging technologies and artificial intelligence to bring new, real-time, intraoperative cancer visualization capabilities to the operating room in order to improve the quality of cancer resections, enhance patient outcomes and reduce economic burden across the healthcare continuum.
Dasi Simulations | Teri Sirset, CEO
Improving the quality of care for Structural Heart Disease patients by providing innovative personalized simulations for informed pre-op preparation toward a better quality of life for people with heart disease.
Materna Medical | Tracy MacNeal, President & CEO
Materna Medical is developing solutions to improve pelvic health in women. The company's first product, Milli, is designed to addressed pelvic pain in the general population. Materna is currently developing a second product designed to expedite labor and reduce pelvic damage during the initial stage of labor.
Aspect BioSystems | Tamer Mohamed, CEO
Combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics.
IRegained | Vineet Johnson, CEO
IRegained's MyHand system is a neuro-rehabilitation device to restore motor control to the hand in patients who have sustained brain injury due to stroke, accident, or TBI.
Hexoskin | Pierre-Alexandre Fournier, CEO
Hexoskin Smart Garments utilize embedded textile sensors to continuously monitor vital signs. Hexoskin smart clothing is capable of monitoring cardiac, pulmonary, activity, and sleep vitals.
EndoShape | Jim Kasic, CEO
Minimally invasive medical devices for peripheral vascular and neurovascular. The company's products utilize a shape-memory, biocompatible polymer to achieve better vessel occlusion with fewer devices per procedure than existing metal implants.
Acorn BioLabs | Drew Taylor, CEO
Acorn is developing a non-insaive cryopreservation solution for the preservation of healthy follicle cells for use in cellular treatments.
NovaResp Technologies | Hamed Hanafi, President & Director
NovaResp is developing technology to improve the prediction of respiratory events in patients using positive airway pressure (PAP) machines. The company's platform uses artificial intelligence and machine learning to monitor respiration and prevent detrimental episodes of apnea.
NextSense | Jonathan Berent, CEO & Founder
NextSense is a developer of a real-world monitoring solution to obtain insights into brain health. The company's platform collects longitudinal electroencephalogram (EEG) data from biosensing earbuds that can be worn throughout the day and night.
11 Health & Technologies | Bernhard Gilbey, CEO
11 Health's Virtual HealthCare Ecosystem is a comprehensive platform for managing chronic digestive conditions.
Exciton Pharma | Carla Spina, CSO
Exciton Pharma Corp (EPC) is a late-stage pre-clinical, multi-asset biotech company developing first-in-class compounds for the inclusive treatment of infection and skin diseases.
UpLyft | Craig Misrach, President & CEO
UpLyft is a self-transfer system for patients with limited mobility. The system is easy-to-operate and capable of moving a person from a bed to a wheelchair in 1 minute.
Heart Repair Technologies | Valavanur "Mani" Subramanian, Founder
Heart Repair Technologies is developing minimally invasive transcatheter technology for the repair of functional mitral and tricuspid valve disease in mitigating severe mitral and tricuspid valve regurgitation.
Onkos Surgical | Patrick Treacy, CEO
Onkos Surgical delivers high quality implants and instruments that meet the unique needs of musculoskeletal tumor patients.
nRichDX, Shaun Sanders, Investor Relations Advisor
An emerging leader in the liquid biopsy sample prep market, delivering to downstream molecular testing up to 75X more target material (ctDNA, CTCs, exosomes, etc.) than existing sample prep systems.
Rhaeos | Anna Lisa Somera, CEO
Noninvasive thermal sensor for use in the monitoring of ventricular shunt function.
Abilitech Medical | Angie Conley, CEO
Addressing the stroke rehabilitation market with a suite of mobility devices to support and assist the arms and hands in functional tasks required for independence in daily life.
INDIUS Medical Solutions | Aditya Ingalhalikar, CEO
INDIUS Medical Solutions Inc. is a spinal medical technology company developing end-to-end solutions from an AI based Diagnostics & Surgical Planning software platform to Innovative Spinal Implants for the treatment of Complex Spinal Disorders across the world.
Advanced Scanners | Jeff Levine, CEO
Advanced Scanners is developing a real-time surgical navigation system that will enable the shift to fully-automatic robotic surgical procedures.
Braingrade | Peter Schlecht, CEO
Braingrade is developing a neurostimulation solution for patients with Alzheimer's disease that is intended to help them live longer, more independent lives.
Modulim | Amaan Mazhar, Chief Product Officer
Optical imaging solutions powered by spatial frequency domain imaging that help clinicians assess tissue perfusion for vascular assessment.
Dr. Hologram | James Beckmann, CEO
Dr. Hologram is a telepresence healthcare technology company that develops virtual simulation technology for telemedicine and healthcare education applications.
Vena Vitals | Ray Liu, CEO
Vena Vitals is an early stage med-tech company focused on non-invasive continuous blood pressure monitoring.
SpinTech MRI | Karen Holzberger, President & CEO
The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency. The solution integrates with virtually all MRI systems and manufacturers.
MedTrace Pharma | Martin Stenfeldt, CEO
MedTrace Pharma A/S is a development stage company aiming to innovate PET diagnostic imaging by transforming blood flow quantification.
Promaxo | Dinesh Kumar, COO
Next generation office-based modular MRI and MRI based technologies. Initial focus on advancing the solutions for prostate disease management and other urology and pelvic conditions.